SandboxAQ has acquired Good Chemistry, a computational chemistry company that leverages AI, quantum and other advanced technologies to accelerate drug discovery.
Good Chemistry, which spun out of 1Qbit in 2021, is SandboxAQ’s second acquisition and its first in the AI simulation sector.
“Good Chemistry’s software and existing partnerships will enable us to rapidly accelerate how we bring the benefits of advanced simulation and AI tools to more customers,” said Dr Nadia Carlsten, Vice President of Product at SandboxAQ. “Combining our capabilities will give SandboxAQ an advanced and scalable computing platform for highly accurate chemical simulation on a scale that makes impactful use cases such as new drug and material synthesis possible.”
Good Chemistry founder and CEO Arman Zaribafiyan will join SandboxAQ as Head of Product for AI Simulation Platforms. The company’s computational and quantum chemists, AI software developers, machine-learning engineers, and quantum computing scientists will join the existing SandboxAQ simulation teams.
“The rapid advances in AI, quantum, cloud and high-performance computing have unlocked endless opportunities for companies like Good Chemistry and SandboxAQ to reinvent the way we think about chemistry, discover ways to make products safer, stronger and more sustainable, and reshape the fabric of our world,” said Zaribafiyan. “Leveraging the broader SandboxAQ reach and domain expertise will supercharge the capabilities of our platform.”
Attending SLAS2024? Don’t miss Andrea Bortolato, Director of Drug Discovery at SandboxAQ, in the Ignite Theater on Monday 5 February, speaking on the topic ‘Combining physics-based methods with AI to maximise the success and speed of drug discovery and development.’